register

Marketing & Strategy

Reimagine the ‘new normal’ of HCP engagement

Health Industry Hub | November 30, 2020 |
[Total: 1    Average: 5/5]

Marketing & Strategy: The greatest danger in times of turbulence is not the turbulence, it is to act with yesterday’s logic. Peter Drucker

As a result of COVID-19, the traditional HCP customer engagement models are evolving into a ‘new normal’.

In a recent interview with Health Industry Hub, Ross Murray, Strategic Partnership Director at Australian Doctor Group (ADG), discussed the emerging trends in customer engagement, the future of face-to-face HCP interactions and the impact of digital marketing and personalised content delivery on brand management.

  1. What are the key emerging trends impacting clinicians and how does this influence pharma’s marketing and commercial engagement with HCPs?
  2. How can companies bridge the gap between f2f and virtual engagement to achieve a sustainable competitive advantage in the ‘new normal’?
  3. How are innovative brands leveraging data and analytics to understand where digital marketing is influencing HCP behaviour in order to complement field force activity and drive ROI?
  4. What are the key barriers to delivering and optimising content in an agile manner to meet clinician needs?
  5. How does digital unlock more value from pharma marketing investments?

Human Resources

PAIG co-chairs reflect on industry progress in D&I with sights set on next phase goals

Health Industry Hub | January 17, 2022 |

Human Resources: In this Health Industry Hub podcast, Medicines Australia’s PAIG (Pharma Australia Inclusion Group) co-chairs reflect on their contribution […]

More


News & Trends - Medical Technology

MedTech News -

Stryker announces fellowships for medtech partner projects

Health Industry Hub | January 17, 2022 |

MedTech News: Stryker announced two of its partner research projects have secured fellowship funding from the Australian government’s Researcher Exchange […]

More


News & Trends - Pharmaceuticals

Pharma News - New guidelines recommend Eli Lilly and GSK drugs in treating COVID-19 patients

New guidelines recommend Eli Lilly and GSK drugs in treating COVID-19 patients

Health Industry Hub | January 17, 2022 |

Pharma News: Update to international guidelines recommend two new drugs for the treatment of COVID-19. Eli Lilly’s oral JAK inhibitor, […]

More


News & Trends - Pharmaceuticals

Pharma News -

Novartis shifts focus as CAR T-cell therapy fails to add benefit in non-Hodgkin lymphoma

Health Industry Hub | January 17, 2022 |

Pharma News: Novartis’ chimeric antigen receptor (CAR) T-cell therapy was not found to improve event-free survival over what was seen […]

More